Akili Provides Corporate Updates

DENVER, Colo., Apr 30, 2024 (247marketnews.com)- Akili, Inc. (Nasdaq:AKLI) commented on multiple corporate updates, including revisions to its strategic distribution agreement in which Shionogi & Co. canceled and forgave a $5 million long-term debt obligation and agreed to make certain payments for SDT-001, the Japanese, localized version of Akili’s AKL-T01 digital treatment, marketed as EndeavorRx in the United States. Additionally, Akili will receive an upfront payment of $10.5 million in consideration for the elimination of future royalty payments and certain future milestone payments. Akili will also be eligible to receive up to a total of $4.5 million from Shionogi in consideration of Akili development and support services, with at least $1.5 million of such services fees payable up front, and up to a total of $3.0 million from Shionogi in potential regulatory milestone payments. SDT-001 is currently under marketing approval review in Japan as a potential digital treatment for children and adolescents with attention-deficit/hyperactivity disorder (“ADHD”).

Akili’s board of directors also initiated a process, currently ongoing, to evaluate potential strategic alternatives to maximize shareholder value, in which the board of directors will evaluate, together with its external advisors, a range of potential strategic alternatives.

Furthermore, Akili’s board of directors approved a revised operating plan and budget for the remainder of 2024 that lowers operating expenses, including a 46% workforce reduction.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (AKLI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.